APA (7th ed.) Citation

CLA, D., LS, B., TC, M., SK, M., FK, W., A, S., . . . JB, H. (2023). New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option. Clinical & experimental metastasis, 40(1), 95. https://doi.org/10.1007/s10585-022-10193-4

Chicago Style (17th ed.) Citation

CLA, Dewald, Becker LS, Meine TC, Maschke SK, Wacker FK, Saborowski A, Vogel A, and Hinrichs JB. "New Perspectives in Unresectable Cholangiocarcinoma? Evaluation of Chemosaturation with Percutaneous Hepatic Perfusion as a Palliative Treatment Option." Clinical & Experimental Metastasis 40, no. 1 (2023): 95. https://doi.org/10.1007/s10585-022-10193-4.

MLA (9th ed.) Citation

CLA, Dewald, et al. "New Perspectives in Unresectable Cholangiocarcinoma? Evaluation of Chemosaturation with Percutaneous Hepatic Perfusion as a Palliative Treatment Option." Clinical & Experimental Metastasis, vol. 40, no. 1, 2023, p. 95, https://doi.org/10.1007/s10585-022-10193-4.